Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trialJie Wu, Xiangmei Chen, Zhaohui Ni et al.|Journal of Chinese Integrative Medicine|2021Cited by 6
P0394EFFICACY AND SAFETY OF A CHINESE PATENT MEDICINE-SHENYANKANGFU TABLETS FOR PRIMARY GLOMERULONEPHRITIS:A RANDOMISED CONTROLLED TRIALJie Wu, Xusheng Liu, Shuwei Duan et al.|Nephrology Dialysis Transplantation|2020Cited by 0
Potential molecular mechanism of Yishen capsule in the treatment of diabetic nephropathy based on network pharmacology and molecular docking technologyYaling Hu, Jingai Fang|Research Square|2021Cited by 0